CN102816147B - 甲磺酸氟马替尼晶型b及其制备方法和用途 - Google Patents
甲磺酸氟马替尼晶型b及其制备方法和用途 Download PDFInfo
- Publication number
- CN102816147B CN102816147B CN201110163226.XA CN201110163226A CN102816147B CN 102816147 B CN102816147 B CN 102816147B CN 201110163226 A CN201110163226 A CN 201110163226A CN 102816147 B CN102816147 B CN 102816147B
- Authority
- CN
- China
- Prior art keywords
- crystal form
- methylsulfonic acid
- acid fluorine
- fluorine imatinib
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110163226.XA CN102816147B (zh) | 2011-06-09 | 2011-06-09 | 甲磺酸氟马替尼晶型b及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110163226.XA CN102816147B (zh) | 2011-06-09 | 2011-06-09 | 甲磺酸氟马替尼晶型b及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102816147A CN102816147A (zh) | 2012-12-12 |
CN102816147B true CN102816147B (zh) | 2016-06-08 |
Family
ID=47300639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110163226.XA Active CN102816147B (zh) | 2011-06-09 | 2011-06-09 | 甲磺酸氟马替尼晶型b及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102816147B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105198860A (zh) * | 2014-06-12 | 2015-12-30 | 江苏豪森药业股份有限公司 | 新的甲磺酸氟马替尼晶型及其制备方法和用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1939910A (zh) * | 2004-12-31 | 2007-04-04 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
-
2011
- 2011-06-09 CN CN201110163226.XA patent/CN102816147B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1939910A (zh) * | 2004-12-31 | 2007-04-04 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
Non-Patent Citations (1)
Title |
---|
synthesis,crystal structure,and spectral characterization of flumatinib mesyate;Gang Xu,等;《Synthetic Communications》;20100805;第40卷;第2564-2570页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102816147A (zh) | 2012-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hameed et al. | Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016) | |
ES2705342T3 (es) | Co-cristales de (S)-N-metil-8-(1-((2'-metil-[4,5'-bipirimidin]-6-il)amino)propan-2-il)quinolin-4-carboxamida y derivados deuterados de la misma como inhibidores de DNA-PK | |
Lord et al. | Pharmacology of a novel central nervous system–penetrant P2X7 antagonist JNJ-42253432 | |
CN103874686B (zh) | 用于抑制烟酰胺磷酸核糖基转移酶(nampt)的哌啶衍生物和组合物 | |
US10005776B2 (en) | Compounds as NIK inhibitors | |
CN105593224A (zh) | 作为溴结构域抑制剂的新型喹唑啉酮类化合物 | |
CN102459242B (zh) | 苯氧基甲基杂环化合物 | |
CN105705504A (zh) | 去泛素化酶抑制剂及其使用方法 | |
TW201026676A (en) | A method of inhibiting hepatitis C virus by combination of a 5,6-dihydro-1H-pyridin-2-one and one or more additional antiviral compounds | |
KR20190003608A (ko) | 질환 치료용 이-치환된 피라졸 화합물 | |
CA2890359A1 (en) | Substituted gemcitabine aryl amide analogs and treatment methods using same | |
CA2884832C (en) | Means and method for treating solid tumours | |
CN106432246A (zh) | 杂芳化合物及其在药物中的应用 | |
CN104364248B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN104011048B (zh) | 作为磷酸二酯酶抑制剂的[1,2,4]三唑并吡啶类化合物及其应用 | |
CN105769846A (zh) | 一种gpr35激动剂及其应用 | |
CN104706604A (zh) | 一种吡仑帕奈冻干口崩片及其制备方法 | |
CN102816147B (zh) | 甲磺酸氟马替尼晶型b及其制备方法和用途 | |
CN108430978A (zh) | 3-羟基-喹唑啉-2,4-二酮衍生物及其作为核酸酶调节剂的用途 | |
CN105198860A (zh) | 新的甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN103509007B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
ES2864405T3 (es) | Compuesto de (hetero)arilamida para inhibir la actividad de proteína quinasa | |
CN102816146A (zh) | 甲磺酸氟马替尼晶型a及其制备方法和用途 | |
CN103509006B (zh) | 甲磺酸氟马替尼晶型及其制备方法和用途 | |
CN102552269A (zh) | SBT在作为GSK-3β的抑制剂方面的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. Address before: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant before: Jiangsu Hansoh Pharmaceutical Group Lianyungang Hongchuang Medical Co., Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160315 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. Address before: 222006 Jiangsu province Lianyungang Kaitai Dapu Road Industrial Area Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |